blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1417227

EP1417227 - PEPTIDES EEFECTIVE IN THE TREATMENT OF TUMORS AND OTHER CONDITIONS REQUIRING THE REMOVAL OR DESTRUCTION OF CELLS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.11.2007
Database last updated on 29.06.2024
Most recent event   Tooltip11.09.2009Lapse of the patent in a contracting state
New state(s): TR		published on 14.10.2009  [2009/42]
Applicant(s)For all designated states
NYMOX CORPORATION
9900 Blvd., Cavendish, Suite 306 St. Laurent
Québec H4M 3V2 / CA
[2007/02]
Former [2004/20]For all designated states
Nymox Corporation
9900 Blvd., Cavendish, Suite 306
St. Laurent Québec H4M 3V2 / CA
Inventor(s)01 / AVERBACK, Paul, A.
383 Lakeshore Road
Beaconsfield, Québec H9W 4J1 / CA
 [2004/20]
Representative(s)Plougmann Vingtoft a/s
Strandvejen 70
2900 Hellerup / DK
[N/P]
Former [2004/20]Plougmann & Vingtoft A/S
Sundkrogsgade 9, P.O. Box 831
2100 Copenhagen O / DK
Application number, filing date02748516.819.07.2002
[2004/20]
WO2002CA01105
Priority number, dateUS20010306150P19.07.2001         Original published format: US 306150 P
US20010306161P19.07.2001         Original published format: US 306161 P
US20010331477P16.11.2001         Original published format: US 331477 P
[2004/20]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03008443
Date:30.01.2003
Language:EN
[2003/05]
Type: A2 Application without search report 
No.:EP1417227
Date:12.05.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 30.01.2003 takes the place of the publication of the European patent application.
[2004/20]
Type: B1 Patent specification 
No.:EP1417227
Date:10.01.2007
Language:EN
[2007/02]
Search report(s)International search report - published on:EP27.11.2003
ClassificationIPC:C07K14/47, A61K38/17
[2005/35]
CPC:
C07K14/4711 (EP,US); C07K14/47 (KR); A61P1/00 (EP);
A61P1/02 (EP); A61P1/04 (EP); A61P13/00 (EP);
A61P13/08 (EP); A61P13/10 (EP); A61P15/00 (EP);
A61P17/00 (EP); A61P17/02 (EP); A61P17/04 (EP);
A61P17/06 (EP); A61P17/12 (EP); A61P17/14 (EP);
A61P19/00 (EP); A61P19/04 (EP); A61P21/00 (EP);
A61P25/28 (EP); A61P27/00 (EP); A61P27/02 (EP);
A61P27/16 (EP); A61P29/00 (EP); A61P3/00 (EP);
A61P3/02 (EP); A61P31/00 (EP); A61P31/04 (EP);
A61P31/12 (EP); A61P33/00 (EP); A61P35/00 (EP);
A61P37/04 (EP); A61P37/06 (EP); A61P39/00 (EP);
A61P39/02 (EP); A61P41/00 (EP); A61P43/00 (EP);
A61P5/00 (EP); A61P9/00 (EP); A61P9/10 (EP);
A61K38/00 (EP,US); C07K2319/00 (EP,US) (-)
Former IPC [2004/20]C07K14/47, C12N15/12, A61K38/17, A61P35/00, C07K19/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/20]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:PEPTIDE FÜR DIE BEHANDLUNG VON TUMOREN UND ANDEREN ZUSTÄNDEN, DIE DAS ENTFERNEN ODER ZERSTÖREN VON ZELLEN ERFORDERN[2004/20]
English:PEPTIDES EEFECTIVE IN THE TREATMENT OF TUMORS AND OTHER CONDITIONS REQUIRING THE REMOVAL OR DESTRUCTION OF CELLS[2004/20]
French:PEPTIDES EFFICACES DANS LE TRAITEMENT DE TUMEURS ET D'AUTRES ETATS PATHOLOGIQUES NECESSITANT L'ABLATION OU LA DESTRUCTION DE CELLULES[2004/20]
Entry into regional phase13.02.2004National basic fee paid 
13.02.2004Designation fee(s) paid 
13.02.2004Examination fee paid 
Examination procedure14.02.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
13.02.2004Examination requested  [2004/20]
03.05.2004Amendment by applicant (claims and/or description)
23.12.2004Despatch of a communication from the examining division (Time limit: M04)
14.04.2005Reply to a communication from the examining division
28.10.2005Communication of intention to grant the patent
10.03.2006Fee for grant paid
10.03.2006Fee for publishing/printing paid
15.05.2006Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
Divisional application(s)EP07000383.5  / EP1847550
Opposition(s)11.10.2007No opposition filed within time limit [2007/51]
Request for further processing for:06.06.2006Request for further processing filed
06.06.2006Full payment received (date of receipt of payment)
Request granted
23.06.2006Decision despatched
Fees paidRenewal fee
13.02.2004Renewal fee patent year 03
20.07.2005Renewal fee patent year 04
27.11.2006Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.07.200605   M06   Fee paid on   27.11.2006
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY10.01.2007
CZ10.01.2007
DK10.01.2007
EE10.01.2007
FI10.01.2007
SK10.01.2007
TR10.01.2007
SE10.04.2007
BG11.04.2007
GR11.04.2007
PT11.06.2007
[2009/42]
Former [2009/34]CY10.01.2007
CZ10.01.2007
DK10.01.2007
EE10.01.2007
FI10.01.2007
SK10.01.2007
SE10.04.2007
BG11.04.2007
GR11.04.2007
PT11.06.2007
Former [2009/10]CZ10.01.2007
DK10.01.2007
EE10.01.2007
FI10.01.2007
SK10.01.2007
SE10.04.2007
BG11.04.2007
GR11.04.2007
PT11.06.2007
Former [2008/22]CZ10.01.2007
DK10.01.2007
FI10.01.2007
SK10.01.2007
SE10.04.2007
BG11.04.2007
GR11.04.2007
PT11.06.2007
Former [2008/02]CZ10.01.2007
DK10.01.2007
FI10.01.2007
SK10.01.2007
SE10.04.2007
BG11.04.2007
PT11.06.2007
Former [2007/51]DK10.01.2007
FI10.01.2007
SK10.01.2007
SE10.04.2007
BG11.04.2007
PT11.06.2007
Former [2007/46]DK10.01.2007
FI10.01.2007
SE10.04.2007
BG11.04.2007
PT11.06.2007
Former [2007/38]FI10.01.2007
SE10.04.2007
BG11.04.2007
PT11.06.2007
Cited inInternational search[X]CN1300783  ;
 [X]WO9838204  (GEN HOSPITAL CORP [US], et al) [X] 1-34 * page 1 - page 7; figure 1; claim 33 *;
 [X]US5948888  (DE LA MONTE SUZANNE [US], et al) [X] 1-34 * SEQ ID NO:120;; column 4 - column 6 *;
 [X]WO0034477  (INCYTE PHARMA INC [US], et al) [X] 1-34 * SEQ ID NO:55;; page 4; figures 1A,1B; claims 19,20 *;
 [X]WO0055198  (HUMAN GENOME SCIENCES INC [US], et al) [X] 1-34 * SEQ ID NO:119;; page 150 - page 186 *;
 [X]WO0056767  (HUMAN GENOME SCIENCES INC [US], et al) [X] 1-34 * SEQ ID NO:121; page 141 - page 184 *;
 [X]WO0058339  (HUMAN GENOME SCIENCES INC [US], et al) [X] 1-34 * SEQ ID NO:116;;; examples 34-52 *;
 [X]WO0058495  (HUMAN GENOME SCIENCES INC [US], et al) [X] 1-34 * SEQ ID NOS:133 and 153;; page 145 - page 190 *;
 [X]WO0063230  (HUMAN GENOME SCIENCES INC [US], et al) [X] 1-34 * SEQ ID NO:135;; page 152 - page 197 *;
 [X]WO0146237  (BIOWINDOW GENE DEV INC [CN], et al) [X] 1-34 * abstract *;
 [PX]WO02097030  (NYMOX CORP [CA], et al) [PX] 1-34* the entire document, in particular SEQ ID NOs:19,21,22,31,37-40,49-51 and claims 1-31 *;
 [X]  - GOLUBNITSCHAJA-LABUDOVA O ET AL., "Altered gene expression in lymphocytes of patients with normal-tension glaucoma", CURRENT EYE RESEARCH, (2000), vol. 21, no. 5, pages 867 - 876, XP009002181 [X] 1-34 * the whole document *

DOI:   http://dx.doi.org/10.1076/ceyr.21.5.867.5534
 [X]  - DE LA MONTE SM ET AL., "Characterization of the AD7C-NTP cDNA Expression in Alzheimer's Disease and Meassurement of a 41-kD Protein in Cerebrospinal Fluid", JOURNAL OF CLINICAL INVESTIGATION, (199712), vol. 100, no. 12, pages 3093 - 3104, XP002199243 [X] 1-34 * abstract *

DOI:   http://dx.doi.org/10.1172/JCI119864
 [X]  - DATABASE WPI, 1, Derwent World Patents Index, Database accession no. 2001-530465, XP002241203 & CN1300783 A 20010627 (SHENGYUAN GENE DEV CO LTD SHANGHAI) [X] 1-34 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.